- Zug, Switzerland
- On-site
- US$284,250 – US$473,750 pa
- Director
Leads clinical development for GU oncology assets, designing and executing Phase 1-3 interventional trials and serving as a core member of the Clinical Matrix Team. Provides real-time medical monitoring, safety review with pharmacovigilance, and authors clinical study reports and regulatory responses. Builds external expert relationships and represents the company at advisory boards and medical meetings.